We first analyzed the percentage of CD66b+ neutrophils in peripheral blood and found that it was significantly increased in patients with active IBD compared with that in patients with IBD in remission and healthy donors (Figures 1(a) and 1(b)). This evidence concerns the gene CEACAM8 and inflammatory bowel disease.